BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16309239)

  • 1. Adenovirus-mediated transfer of FRNK augments drug-induced cytotoxicity in cultured SCCHN cells.
    Kornberg LJ
    Anticancer Res; 2005; 25(6B):4349-56. PubMed ID: 16309239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ad-fRNK and Ad-p53 cooperate to augment drug-induced death of a transformed cell line.
    Kornberg L
    Anticancer Res; 2006; 26(4B):3025-31. PubMed ID: 16886630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of inducible overexpression of FAK-related non-kinase (FRNK) on a transformed epithelial cell line.
    Kornberg L; Fleigel J
    Anticancer Res; 2003; 23(1A):91-7. PubMed ID: 12680199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation.
    van Nimwegen MJ; Verkoeijen S; van Buren L; Burg D; van de Water B
    Cancer Res; 2005 Jun; 65(11):4698-706. PubMed ID: 15930288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [FAK related non-kinase (FRNK) inhibits migration of a human breast carcinoma cell line MDA-MB-435].
    Qin J; Liu ZX
    Ai Zheng; 2006 Jul; 25(7):833-8. PubMed ID: 16831273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo.
    Aguirre Ghiso JA
    Oncogene; 2002 Apr; 21(16):2513-24. PubMed ID: 11971186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
    Hauck CR; Sieg DJ; Hsia DA; Loftus JC; Gaarde WA; Monia BP; Schlaepfer DD
    Cancer Res; 2001 Oct; 61(19):7079-90. PubMed ID: 11585739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal adhesion kinase overexpression induces enhanced pathological retinal angiogenesis.
    Kornberg LJ; Shaw LC; Spoerri PE; Caballero S; Grant MB
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4463-9. PubMed ID: 15557455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells.
    Agochiya M; Brunton VG; Owens DW; Parkinson EK; Paraskeva C; Keith WN; Frame MC
    Oncogene; 1999 Oct; 18(41):5646-53. PubMed ID: 10523844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
    Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
    Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells.
    Slack JK; Adams RB; Rovin JD; Bissonette EA; Stoker CE; Parsons JT
    Oncogene; 2001 Mar; 20(10):1152-63. PubMed ID: 11313859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells.
    Haskell H; Natarajan M; Hecker TP; Ding Q; Stewart J; Grammer JR; Gladson CL
    Clin Cancer Res; 2003 Jun; 9(6):2157-65. PubMed ID: 12796381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal adhesion kinase promotes the aggressive melanoma phenotype.
    Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
    Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
    Golubovskaya VM; Virnig C; Cance WG
    Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-8-induced migratory responses through CXCR1 and CXCR2: association with phosphorylation and cellular redistribution of focal adhesion kinase.
    Feniger-Barish R; Yron I; Meshel T; Matityahu E; Ben-Baruch A
    Biochemistry; 2003 Mar; 42(10):2874-86. PubMed ID: 12627953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression.
    Canel M; Secades P; Garzón-Arango M; Allonca E; Suarez C; Serrels A; Frame M; Brunton V; Chiara MD
    Br J Cancer; 2008 Apr; 98(7):1274-84. PubMed ID: 18349846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
    Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D cell cultures of human head and neck squamous cell carcinoma cells are radiosensitized by the focal adhesion kinase inhibitor TAE226.
    Hehlgans S; Lange I; Eke I; Cordes N
    Radiother Oncol; 2009 Sep; 92(3):371-8. PubMed ID: 19729215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.
    Sood AK; Coffin JE; Schneider GB; Fletcher MS; DeYoung BR; Gruman LM; Gershenson DM; Schaller MD; Hendrix MJ
    Am J Pathol; 2004 Oct; 165(4):1087-95. PubMed ID: 15466376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.
    Luangdilok S; Box C; Patterson L; Court W; Harrington K; Pitkin L; Rhŷs-Evans P; O-charoenrat P; Eccles S
    Cancer Res; 2007 Aug; 67(16):7907-16. PubMed ID: 17699797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.